Israel to build AI supercomputer amid rising GenAI status
Israel now ranks third globally in the world for GenAI development and needs continued investment to stay ahead of the competition.
Israel now ranks third globally in the world for GenAI development and needs continued investment to stay ahead of the competition.
One innovation in diagnostic technology is paving the way for huge shifts in the way experts diagnose, monitor and treat diseases — especially cancer.
The move represents a vote of confidence from the social media giant in Israel’s ripe AI potential.
Israeli unicorn Verbit has launched a new version of its AI transcription platform specifically designed for use in the courtroom.
Corsound hopes to fight online fraudsters by differentiating a real voice from a cloned one, and identifying whether a photo of a new customer matches their voice.
Designed and developed by Israeli scientists, Lunar Lake is set to boost performance of Microsoft-powered Copilot+ PCs, the most intelligent Windows PCs.
After trying to oust OpenAI’s CEO due to safety concerns, Ilya Sutskever cofounds Safe Superintelligence (SSI) firm based in Tel Aviv and Palo Alto.
The ‘smart antibody’ maker will receive $10 mil. in the initial stage of the agreement to develop molecules that would be used in anti-cancer drugs.
Founders say Heyoosh is the world’s first AI-based personal matchmaker that steers away from predatory tactics of Tinder and similar services.
Greeneye Technology’s precision spraying can offer farmers in and around Nebraska a major productivity boost.
New startup Seven AI wins $36 million in funding for its software that reinvents the command center that monitors an organization’s IT infrastructure.
Aporia’s Guardrails for Multimodal AI set to enhance the safety and reliability of the latest AI capabilities combining text, audio, video and images.
Sightful has opened preorders for its Spacetop G1 laptop, which boasts a 100-inch augmented reality screen visible only to the user
The German company’s acquisition is one of the most expensive in 2024.
The breakthrough methodology promises more precise cancer treatment.